CollPlant Biotechnologies...

NASDAQ: CLGN · Real-Time Price · USD
2.50
-0.11 (-4.21%)
At close: Aug 15, 2025, 3:57 PM
2.56
2.40%
After-hours: Aug 15, 2025, 06:26 PM EDT

CollPlant Biotechnologies Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-13.87M -16.61M -17.42M -17.47M -7.5M -7.02M -6.73M -6.73M -16.78M -16.93M -16.3M -14.99M -13.75M 237K 1.1M 4.88M 5.95M
Depreciation & Amortization
1M 1.04M 1.08M 1.1M 1.1M 1.1M 1.11M 1.12M 1.12M 1.08M 1.01M 922K 840K 773K 715K 685K 669K
Stock-Based Compensation
1.81M 1.72M 1.86M 1.86M 1.71M 1.94M 1.81M 1.97M 2.23M 2.17M 2.01M 1.7M 1.57M 1.6M 1.83M 1.83M 1.81M
Other Working Capital
-519.95K -351.95K 37.68K 110.68K 42.94K 126.94K 122.33K -127.77K -245.77K -639.77K -232.1K -435K -759K -761K -1.15M 242K 295K
Other Non-Cash Items
9.7K 746.7K 733.63K 758.63K 809.63K 351.63K 343K 336K 611K 521K 679K 798K 319K -28K 112K 45K 154K
Deferred Income Tax
n/a n/a 23.61K 157.6K 157.6K 157.6K 134K n/a n/a n/a -206K -307K -226K -294K -141K -33K -150K
Change in Working Capital
-963.7K -372.7K 1.45M 11.54M 1.85M 791.54K -434K -10.42M -1.11M -544K 35K -521K -468K 216K -295K 215K 697K
Operating Cash Flow
-12.01M -14.09M -12.89M -2.67M -2.48M -2.68M -3.76M -13.72M -13.94M -13.7M -12.77M -12.4M -11.71M 2.5M 3.32M 7.63M 9.13M
Capital Expenditures
-410K -483K -642.38K -745.38K -880.38K -943.38K -1.03M -1.11M -1.16M -1.32M -1.52M -1.83M -1.71M -1.59M -1.22M -720K -613K
Cash Acquisitions
n/a n/a 65.61K 65.61K 65.61K 65.61K n/a 249.5K 204.5K 204.5K 238.29K -11.21K 33.79K 33.79K n/a n/a n/a
Purchase of Investments
n/a n/a -203.38K -202.47K -260.52K -260.52K 19.94M 20.1M 156.42K 156.42K -29.84M -20M -30.05M -60.05M -50.05M -60.05M -30M
Sales Maturities Of Investments
n/a n/a 143K 143K 143K 143K -50.24M -50.63M -30.58M -392.92K 49.85M 60.24M 40.19M 10M 10M n/a n/a
Other Investing Acitivies
-55K -56K -200K -200.91K -144.86K -144.86K 30.24M 30.22M 30.27M 60.45M 30.25M 40.23M 10.18M -20.05M -20.12M -30.14M -138K
Investing Cash Flow
-465K -539K -837.15K -940.15K -1.08M -1.14M -1.09M -1.17M -1.11M 28.92M 18.75M 28.44M -1.49M -31.56M -21.22M -30.72M -613K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.41M -4.41M -4.42M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 9K 9K 225K 314K 1.11M 1.51M 1.29M 1.2M 1.87M 1.62M 3.36M 4.72M 6.02M 10.28M 8.55M 7.19M
Financial Cash Flow
n/a 9K 5.05K 221.05K 310.05K 1.1M 1.51M 1.28M 1.16M 1.83M 1.57M 3.33M 4.72M 38.76M 38.61M 36.88M 35.47M
Net Cash Flow
-12.49M -14.77M -13.6M -3.43M -3.55M -3.17M -4.04M -14.14M -14.5M 16.49M 7.05M 18.83M -8.63M 9.85M 20.76M 13.82M 44.14M
Free Cash Flow
-12.42M -14.58M -13.53M -3.41M -3.36M -3.62M -4.79M -14.83M -15.1M -15.01M -14.29M -14.24M -13.42M 912K 2.1M 6.91M 8.52M